You are required to be logged in to access the full website
Click here if you have forgotten your username or password
28 October 2026 - US-based specialty pharmaceutical company US WorldMeds Ventures LLC announced on Tuesday a definitive merger agreement under which it has acquired Orbus Therapeutics Inc, a privately held pharmaceutical company developing investigat...
28 October 2026 - US-based pharmaceutical company DifGen Pharmaceuticals LLC announced on Tuesday the successful completion of the European Decentralised Procedure (DCP) for Tafamidis 61 mg Capsules, marking the company's first major regulatory ...
28 October 2026 - US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Tuesday that its board of directors has declared a dividend of USD2.52 per share for the fourth quarter of 2026.This amount is unchanged from the previous quarterly divid...
28 October 2026 - Japanese pharmaceutical company Astellas Pharma Inc (TSE:4503) and Australian biotechnology company Audax Biosciences Pty Ltd announced on Tuesday that they have entered into an exclusive option and licence agreement for DAX-044, Au...
28 October 2026 - Lynk Pharmaceuticals Co Ltd, a Chinese drug development company focused on immune and inflammatory diseases, on Tuesday announced positive long-term results from its pivotal Phase III clinical trial evaluating zemprocitinib, an inve...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe